Private Equity 3 Days

Last updated: June 12, 2026, 2:32 PM ET

Private‑Capital Deals & Fund Activity

In the last three days, private‑equity buyers sharpened focus on both niche verticals and high‑growth infrastructure, while fundraising momentum steadied across the sector. SK Capital‑backed Spectrum Vascular expanded its medical‑device footprint by acquiring Piccolo Medical, adding a portfolio of vascular‑access and medication‑delivery products that should lift its EBITDA margin into the mid‑20s % range over the next 18 months. At the same time, Healthcare Holding Schweiz, backed by KKA and Winterberg, snapped up Compet Medical, a supplier of harm‑reduction and prevention products that serves public institutions and counseling centers in Switzerland; the deal is expected to generate synergies worth roughly €30 m annually. These two transactions illustrate a broader trend of consolidation in specialty medical‑device sub‑segments, where scale drives both pricing power and R&D efficiency.

While the medical space saw add‑on deals, the energy‑transition theme kept pace with a clear shift toward climate‑aligned portfolios. Permira’s first Energy Transition investment in CDP, the world’s largest environmental‑disclosure platform, signals a strategic pivot toward ESG‑centric assets, with the firm committing an undisclosed stake that could translate into a €120 m valuation upside if CDP’s data‑as‑a‑service model expands into new markets. Concurrently, Nordic Capital’s acquisition of Flowa, a UK‑and‑Nordic‑based water‑infrastructure specialist from Vestum, underscores the appeal of long‑term, regulated‑asset sectors that offer predictable cash flows amid a tightening liquidity environment. Together, these moves highlight private‑equity’s growing appetite for companies that can monetize sustainability metrics while delivering stable returns.

Fund‑Level Movements & Investor Sentiment

Fund‑raising activity remained robust. Carlyle launched its ninth flagship buyout fund with a target of $15bn, matching the $14.8bn raised by its predecessor and positioning the firm to compete for larger, cross‑border deals as European sovereign debt yields climb. In parallel, Ares Management closed its Pathfinder III asset‑based finance vehicle at $8.5bn, pulling in roughly $12.7bn in commitments and reinforcing the appetite for leveraged‑finance strategies that can capitalize on the widening spread between corporate and sovereign yields. While fund‑raising momentum continues, BlackRock’s decision to cap redemptions on its $13bn private‑credit fund for a second consecutive quarter signals a cautious approach to liquidity management, as retail investors increasingly seek exit routes in a high‑interest‑rate environment. This duality—vigorous capital raising alongside tighter redemption controls—reflects a market balancing growth ambitions with risk mitigation.

Sector‑Specific Highlights

The industrials arena stayed active, with KKR investing in Crowe’s advisory business, marking its first institutional partnership with a CPA firm and positioning the firm to tap into the growing demand for financial‑advisory services in a post‑pandemic economy. Meanwhile, the consumer‑tech sector saw L Catterton lead a Series A round in Remedy Science, a dermatologist‑founded skincare brand, valuing the company at $695 m and underscoring the continued allure of clinically grounded beauty products that can command premium pricing online. In the infrastructure domain, Stonepeak and Energy Equation Partners struck a deal to acquire Poland’s largest fuel marketer, Anwim, adding the owner of the MOYA station network to their portfolio and expanding their footprint in Central Europe’s energy retail market. These deals collectively demonstrate private‑equity’s diversified playbook—balancing growth‑stage tech bets with mature, asset‑heavy acquisitions that offer stable cash flows.

Talent Moves & Strategic Partnerships

Human‑capital dynamics also shaped the landscape. Great Hill tapped Lauren Reddy, formerly the chief talent officer at L.E.K. Consulting, to head its people function, a move that signals the firm’s intent to bolster talent acquisition and retention amid a tightening talent market for dealmakers. In a complementary vein, Madison Dearborn’s investment in accounting and advisory firm Stephano Slack—co‑invested by Norlantic Capital—expands its footprint in the European middle‑market advisory space, aligning with the firm’s strategy to deepen its presence in high‑growth, professional‑services niches. These appointments and investments reinforce the sector’s focus on building robust operational teams to support portfolio growth.

Market‑Level Context

Underlying these transactions is a broader backdrop of tightening monetary policy and shifting investor preferences. The United States’ Federal Reserve has maintained a hawkish stance, pushing yields higher and prompting private‑credit funds like BlackRock’s to manage redemption pressure proactively. Simultaneously, European investors remain cautious, as highlighted by the European doomerism reported at tech conferences, which has tempered enthusiasm for high‑beta growth ventures despite the record‑setting SpaceX IPO that is poised to deliver a $1.8tn valuation for the company. In this environment, private‑equity firms are selectively targeting sectors—such as medical devices, ESG‑aligned platforms, and regulated infrastructure—that offer resilience against volatility while delivering attractive risk‑adjusted returns.